| Product NDC: | 37205-827 |
| Proprietary Name: | Leader Allergy D 12 |
| Non Proprietary Name: | Cetirizine HCl, Pseudoephedrine HCl |
| Active Ingredient(s): | 5; 120 mg/1; mg/1 & nbsp; Cetirizine HCl, Pseudoephedrine HCl |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 37205-827 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA077170 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080514 |
| Package NDC: | 37205-827-62 |
| Package Description: | 4 BLISTER PACK in 1 CARTON (37205-827-62) > 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| NDC Code | 37205-827-62 |
| Proprietary Name | Leader Allergy D 12 |
| Package Description | 4 BLISTER PACK in 1 CARTON (37205-827-62) > 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| Product NDC | 37205-827 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Cetirizine HCl, Pseudoephedrine HCl |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080514 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 5; 120 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |